HANSA BIOPHARMA
Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company that leverages its unique enzyme technology.
HANSA BIOPHARMA
Social Links:
Industry:
Biotechnology Health Care
Founded:
2007-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.hansabiopharma.com
Total Employee:
51+
Status:
Active
Contact:
46 46 16 56 70
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Nginx Microsoft Exchange Online
Similar Organizations
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Current Employees Featured
Founder
Stock Details
Investors List
Novaquest Capital Management
Novaquest Capital Management investment in Grant - Hansa Biopharma
Official Site Inspections
http://www.hansabiopharma.com Semrush global rank: 4.08 M Semrush visits lastest month: 3 K
- Host name: 52.174.176.76
- IP address: 52.174.176.76
- Location: Amsterdam Netherlands
- Latitude: 52.3534
- Longitude: 4.9087
- Timezone: Europe/Amsterdam
- Postal: 1091
More informations about "Hansa Biopharma"
Our leadership | Hansa Biopharma
Renée Aguiar-Lucander is CEO of Hansa Biopharma since April 2025. Prior to joining Hansa, Renée served for seven years as CEO of Calliditas Therapeutics AB where she successfully …See details»
About Hansa Biopharma
Our values. At Hansa Biopharma, we strive to create an inclusive environment that embraces difference and fosters inclusion. We believe that valuing diversity and inclusion will create an …See details»
Pioneering innovative lifesaving treatments - hansabiopharma.com
Highly engaged and committed organization, Hansa is well-positioned to deliver on its strategic priorities in 2023 and become a leading player in rare immunologic diseases. On behalf of the …See details»
Hansa Biopharma appoints Maria Törnsén as Chief ... - Morningstar
11 hours ago LUND, Sweden, May 13, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that Maria Törnsén has been appointed Chief …See details»
Hansa Biopharma appoints Maria Törnsén as Chief Operating …
4 hours ago Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that Maria Törnsén has been appointed Chief Operating Officer (COO) and President U.S. …See details»
Hansa Biopharma - businessabc.net
Feb 25, 2025 Hansa Biopharma was founded in 2003 in Lund, Sweden and is led by Chief Executive Officer Anders Lönner. It is a public company listed on the Stockholm Stock …See details»
Hansa Biopharma - Crunchbase Company Profile
Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases. They concentrate on creating novel, life-saving and life-changing treatments …See details»
Hansa Biopharma - Craft
Oct 29, 2024 Hansa Biopharma has 5 employees at their 1 location and kr171.32 m in annual revenue in FY 2024. See insights on Hansa Biopharma including office locations, competitors, …See details»
Hansa Biopharma AB: Hansa Biopharma publicerar årsredovisning …
Mar 21, 2025 IR @hansabiopharma.com. Stephanie Kenney, VP Global Corporate Affairs [email protected]. Bakgrundsinformation. Om Hansa Biopharma. Hansa …See details»
Hansa Biopharma - LinkedIn
Hansa Biopharma, is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative and life altering treatments for patients with rare immunological ...See details»
Hansa Biopharma Company Profile | Management and Employees …
Www.hansabiopharma.com Hansa Biopharma Profile and History Founded in 2007, Hansa Biopharma is a biopharmaceutical company developing novel immunomodulatory enzymes for …See details»
Hansa Biopharma appoints Maria Törnsén as Chief Operating …
4 hours ago IR @hansabiopharma.com. Stephanie Kenney, VP Global Corporate Affairs [email protected]. Notes to editors. About Hansa Biopharma. Hansa Biopharma …See details»
Hansa Biopharma appoints new Chief Executive Officer
Apr 24, 2025 Under his guidance, Hansa has evolved from a clinical-stage company into a commercial-stage biopharmaceutical organization, navigating both transformative progress …See details»
Hansa Biopharma - MVA
Hansa Biopharma is a pioneering commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving, and life-altering treatments for patients with …See details»
Corporate governance | Hansa Biopharma
Virtual Investor Event. Autoimmune Deep Dive Guillain-Barré Syndrome . Join Hansa Biopharma for an investor event featuring KOLs David R. Cornblath, MD (Johns Hopkins University), and …See details»
Hansa Biopharma AB: Hansa Biopharma appoints Maria Törnsén …
4 hours ago LUND, Sweden, May 13, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that Maria Törnsén has been appointed Chief …See details»
Hansa Biopharma - Products, Competitors, Financials, Employees ...
Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The company is listed on Nasdaq Stockholm under the ticker HNSA. Find out more at …See details»
Hansa Biopharma publishes 2024 Annual and Sustainability Reports
Mar 21, 2025 IR @hansabiopharma.com. Stephanie Kenney, VP Global Corporate Affairs [email protected] Notes to editors. About Hansa Biopharma. Hansa Biopharma AB is a pioneering …See details»
Hansa Biopharma Company Overview, Contact Details
Apr 12, 2024 Hansa Biopharma. Biotechnology Research Lund, Sweden 51-200 Employees. Hansa Biopharma, is a pioneering commercial-stage biopharmaceutical company on a mission …See details»
Join us - Hansa Biopharma
At Hansa, we are dedicated to creating a material change for people living with rare immunological diseases. We leverage our immunomodulatory platform to develop treatments …See details»